Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
Nakahashi
Hirotaka
H
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Tsukamoto
Norifumi
N
Yamane
Arito
A
Saitoh
Takayuki
T
Uchiumi
Hideki
H
Handa
Hiroshi
H
Karasawa
Masamitsu
M
Murakami
Hirokazu
H
Kojima
Masaru
M
Nojima
Yoshihisa
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D019008:Drug Resistance, Neoplasm; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D008297:Male; D009361:Neoplasm Invasiveness; D015434:Panniculitis / Q000175:diagnosis; D036102:Peripheral Blood Stem Cell Transplantation; D011241:Prednisone / Q000008:administration & dosage; D016879:Salvage Therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D040521:Subcutaneous Tissue; D014182:Transplantation, Autologous; D014750:Vincristine / Q000008:administration & dosage; D055815:Young Adult
D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; C027260:pirarubicin; D001215:Asparaginase; D011241:Prednisone